ADIM
ZGNX

Alpha DNA Investment Management’s Zogenix, Inc. ZGNX Stock Holding History

Alpha DNA Investment Management’s Portfolio ZGNX Stock Details ZGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-13
Closed – – 755
2021
Q1 		$0 Hold
13
– – ﹤0.01% 828
2020
Q4 		$0 Buy
+13
New +$266 ﹤0.01% 645

Other funds holding ZGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
IG
ING Group Amsterdam, Netherlands $16.4B AUM 34.6% 1-Year Est. Return

Alpha DNA Investment Management's ZGNX Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Zogenix, Inc. (ZGNX) in Q2 2021, closing a stake of 13 shares.

Alpha DNA Investment Management first reported a position in ZGNX in Q4 2020 and held it in 2 quarters. The position peaked at $0 in Q1 2021. 149 funds tracked by Wall St. Rank hold ZGNX as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining Zogenix, Inc. position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 13 Zogenix, Inc. shares in Q2 2021.
  • Alpha DNA Investment Management first reported a position in Zogenix, Inc. in Q4 2020 and held it in 2 quarters.
  • Alpha DNA Investment Management's Zogenix, Inc. position peaked at $0 in Q1 2021.
  • 149 funds tracked by Wall St. Rank held Zogenix, Inc. as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.